Cart
sales@molnova.com
HIV-1 integrase inhibitor
CAS No. 544467-07-4
HIV-1 integrase inhibitor ( —— )
Catalog No. M14954 CAS No. 544467-07-4
HIV-1 integrase inhibitor is an HIV-1 integrase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIV-1 integrase inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIV-1 integrase inhibitor is an HIV-1 integrase inhibitor.
-
DescriptionHIV-1 integrase inhibitor is an HIV-1 integrase inhibitor.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number544467-07-4
-
Formula Weight247.21
-
Molecular FormulaC11H9N3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESOC(/C(O)=C/C(C1=CC=CC(CN=[N+]=[N-])=C1)=O)=O
-
Chemical Name2-Butenoic acid, 4-[3-(azidomethyl)phenyl]-2-hydroxy-4-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hobaika Z, et al. Neurochem Res. 2010 Jun;35(6):888-93.
2. Kawasuji T, et al. J Med Chem. 2012 Oct 25;55(20):8735-44.
3. Loizidou EZ, et al. Bioorg Med Chem. 2009 Jul 1;17(13):4806-18.
2. Kawasuji T, et al. J Med Chem. 2012 Oct 25;55(20):8735-44.
3. Loizidou EZ, et al. Bioorg Med Chem. 2009 Jul 1;17(13):4806-18.
molnova catalog
related products
-
Pitstop2
Pitstop2 is a selective inhibitor of amphiphysin association of clathrin terminal domain with an IC50 value of 12 μM. Pitstop2 acutely interferes with receptor-mediated endocytosis, entry of HIV, and synaptic vesicle recycling.
-
(±)-BI-D
A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase.
-
Cyclotriazadisulfona...
Cyclotriazadisulfonamide hydrochloride is a selective inhibitor of CD4-targeted HIV entry and inhibits the co-translational translocation of human CD4 into the ER lumen in a signal peptide-dependent way.
